Multilayer Polypeptide Nanoscale Coatings Incorporating IL-12 for the Prevention of Biomedical Device-associated Infections

Overview

Journal Biomaterials

Specialty Biomedical Engineering

Date 2009 Feb 14

PMID 19215980

Citations 35

Authors

Bingyun Li

Bingbing Jiang

Brandon M Boyce

Brock A Lindsey

Affiliations

Soon will be listed here.

Abstract

Biomedical device-associated infection is one of the most common and problematic complications faced by millions of patients worldwide. The current antibiotic therapy strategies face challenges, the most serious of which is antibiotic resistance. Studies have shown that the systemic level of interleukin 12 (IL-12) decreases following major injuries resulting in decreased cell-mediated immune response. Here we report the development of IL-12 nanoscale coatings using electrostatic layer-by-layer self-assembly nanotechnology. We found that IL-12 nanoscale coatings at the implant/tissue interface substantially decrease infections in vivo, and IL-12 nanoscale coatings are advantageous over traditional treatments. This approach could be a revolutionary step toward preventing device-associated infections using a non-antibiotic approach.

Citing Articles

Antimicrobial Peptide Identified via Machine Learning Presents Both Potent Antibacterial Properties and Low Toxicity toward Human Cells.

Wang Q, Yang J, Xing M, Li B Microorganisms. 2024; 12(8).

PMID: 39203524 PMC: 11356914. DOI: 10.3390/microorganisms12081682.

The osteoblast secretome in osteomyelitis.

Granata V, Possetti V, Parente R, Bottazzi B, Inforzato A, Sobacchi C Front Immunol. 2022; 13:1048505.

PMID: 36483565 PMC: 9723341. DOI: 10.3389/fimmu.2022.1048505.

Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis.

Bharadwaj A, Rastogi A, Pandey S, Gupta S, Sohal J Biomed Res Int. 2022; 2022:5419874.

PMID: 36105930 PMC: 9467707. DOI: 10.1155/2022/5419874.

Strategically prolonged release of multiple antibacterial components from a thin film coating for synergistic effects against infections.

Song M, Zhu H, Ye L, Liu C, Xu Z RSC Adv. 2022; 9(56):32683-32690.

PMID: 35529751 PMC: 9073156. DOI: 10.1039/c9ra03365c.

In Vivo Antibacterial Efficacy of Antimicrobial Peptides Modified Metallic Implants─Systematic Review and Meta-Analysis.

Kaur Sandhu A, Yang Y, Li W ACS Biomater Sci Eng. 2022; 8(5):1749-1762.

PMID: 35412810 PMC: 9171719. DOI: 10.1021/acsbiomaterials.1c01307.

References

Orange J, Wolf S, Biron C . Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol. 1994; 152(3):1253-64. View

Shih I, Van Y, Shen M . Biomedical applications of chemically and microbiologically synthesized poly(glutamic acid) and poly(lysine). Mini Rev Med Chem. 2004; 4(2):179-88. DOI: 10.2174/1389557043487420. View

Schmidmaier G, Lucke M, Wildemann B, Haas N, Raschke M . Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury. 2006; 37 Suppl 2:S105-12. DOI: 10.1016/j.injury.2006.04.016. View

OSullivan S, Lederer J, Horgan A, Chin D, Mannick J, Rodrick M . Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg. 1995; 222(4):482-90; discussion 490-2. PMC: 1234878. DOI: 10.1097/00000658-199522240-00006. View

Hsieh C, Macatonia S, Tripp C, Wolf S, OGarra A, Murphy K . Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993; 260(5107):547-9. DOI: 10.1126/science.8097338. View

Trnobranski P . Are we facing a 'post-antibiotic era'?--a review of the literature regarding antimicrobial drug resistance. J Clin Nurs. 1998; 7(5):392-400. DOI: 10.1046/j.1365-2702.1998.00181.x. View

Scott P . IL-12: initiation cytokine for cell-mediated immunity. Science. 1993; 260(5107):496-7. DOI: 10.1126/science.8097337. View

Kalicke T, Schierholz J, Schlegel U, Frangen T, Koller M, Printzen G . Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. J Orthop Res. 2006; 24(8):1622-40. DOI: 10.1002/jor.20193. View

Marriott I, Gray D, Tranguch S, Fowler Jr V, Stryjewski M, Levin L . Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Am J Pathol. 2004; 164(4):1399-406. PMC: 1615361. DOI: 10.1016/S0002-9440(10)63226-9. View

10.

Heinzel F, Schoenhaut D, Rerko R, Rosser L, Gately M . Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med. 1993; 177(5):1505-9. PMC: 2191017. DOI: 10.1084/jem.177.5.1505. View

11.

Garvin K, Feschuk C . Polylactide-polyglycolide antibiotic implants. Clin Orthop Relat Res. 2005; (437):105-10. DOI: 10.1097/01.blo.0000175720.99118.fe. View

12.

Kuriakose M, Chen F, Egilmez N, Jong Y, Mathiowitz E, Delacure M . Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model. Head Neck. 1999; 22(1):57-63. DOI: 10.1002/(sici)1097-0347(200001)22:1<57::aid-hed9>3.0.co;2-k. View

13.

Spolarics Z, Siddiqi M, Siegel J, Garcia Z, Stein D, Denny T . Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med. 2003; 31(6):1722-9. DOI: 10.1097/01.CCM.0000063579.43470.AA. View

14.

Trinchieri G . Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol. 1998; 70:83-243. DOI: 10.1016/s0065-2776(08)60387-9. View

15.

Sypek J, Chung C, Mayor S, Subramanyam J, Goldman S, Sieburth D . Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med. 1993; 177(6):1797-802. PMC: 2191036. DOI: 10.1084/jem.177.6.1797. View

16.

Bajetta E, Del Vecchio M, Mortarini R, Nadeau R, Rakhit A, Rimassa L . Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma. Clin Cancer Res. 1998; 4(1):75-85. View

17.

Nixon M, Jackson B, Varghese P, Jenkins D, Taylor G . Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br. 2006; 88(6):812-7. DOI: 10.1302/0301-620X.88B6.17544. View

18.

Zalavras C, Patzakis M, Holtom P, Sherman R . Management of open fractures. Infect Dis Clin North Am. 2005; 19(4):915-29. DOI: 10.1016/j.idc.2005.08.001. View

19.

Schirmer W, Schirmer J, Townsend M, Fry D . Femur fracture with associated soft-tissue injury produces hepatic ischemia. Possible cause of hepatic dysfunction. Arch Surg. 1988; 123(4):412-5. DOI: 10.1001/archsurg.1988.01400280018002. View

20.

Jiang B, Li B . Tunable drug loading and release from polypeptide multilayer nanofilms. Int J Nanomedicine. 2009; 4:37-53. PMC: 2720742. DOI: 10.2147/ijn.s4970. View